Cargando…

Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG

BACKGROUND: The histone variant H3.3 K27M mutation is a defining characteristic of diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG). This histone mutation is responsible for major alterations to histone H3 post-translational modification (PTMs) and subsequent aberrant gene expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Nichole A., Klein, Rachel Herndon, Kelly, Cailin, Yee, Jennifer, Knoepfler, Paul S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121554/ https://www.ncbi.nlm.nih.gov/pubmed/35590427 http://dx.doi.org/10.1186/s13072-022-00447-6

Ejemplares similares

Ascl1b and Neurod1, instead of Neurog3, control pancreatic endocrine cell fate in zebrafish
por: Flasse, Lydie C, et al.
Publicado: (2013)

Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells
por: Costanzo, Federico, et al.
Publicado: (2022)

Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling
por: Chen, Kuang-Yui, et al.
Publicado: (2020)

Endogenous mammalian histone H3.3 exhibits chromatin-related functions during development
por: Bush, Kelly M, et al.
Publicado: (2013)

Knockout tales: the versatile roles of histone H3.3 in development and disease
por: Klein, Rachel H., et al.
Publicado: (2023)

Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
por: Sarthy, Jay F, et al.
Publicado: (2020)

DIPG-17. TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA USING ALLELE-SPECIFIC SIRNA TARGETING H3.3 K27M MUTANT HISTONE
por: Wentworth, Simon, et al.
Publicado: (2023)

DIPG-76. HISTONE H3 PHOSPHORYLATION IN H3K27M MIDLINE GLIOMAS
por: Zhang, Liang, et al.
Publicado: (2020)

DIPG-27. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION
por: Ehteda, Anahid, et al.
Publicado: (2020)

DIPG-05. HISTONE H3.3 K27M IMPAIRS SER31 PHOSPHORYLATION, RESULTING IN CHROMOSOMAL INSTABILITY, LOSS OF CELL CYCLE CHECKPOINT CONTROL, AND TUMOR FORMATION
por: Day, Charles, et al.
Publicado: (2020)

Live-cell single-molecule dynamics of PcG proteins imposed by the DIPG H3.3K27M mutation
por: Tatavosian, Roubina, et al.
Publicado: (2018)

The Differential Mobilization of Histones H3.1 and H3.3 by Herpes Simplex Virus 1 Relates Histone Dynamics to the Assembly of Viral Chromatin
por: Conn, Kristen L., et al.
Publicado: (2013)

Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals
por: Trovato, Matteo, et al.
Publicado: (2020)

Ascl1 Coordinately Regulates Gene Expression and the Chromatin Landscape during Neurogenesis
por: Raposo, Alexandre A.S.F., et al.
Publicado: (2015)

Correction:The Differential Mobilization of Histones H3.1 and H3.3 by Herpes Simplex Virus 1 Relates Histone Dynamics to the Assembly of Viral Chromatin
por: Conn, Kristen L., et al.
Publicado: (2016)

DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION BEYOND H3-K27M MUTATION
por: Castel, David, et al.
Publicado: (2020)

DIPG-47. DISCOVERING A MOLECULAR BASIS FOR VULNERABILITY OF H3K27M-DMG TO HISTONE DEACETYLASE INHIBITORS
por: Paine, Danyelle, et al.
Publicado: (2023)

Distinct chromatin signature of histone H3 variant H3.3 in human cells
por: Snyers, Luc, et al.
Publicado: (2014)

Beta cell dysfunction induced by bone morphogenetic protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding
por: Urizar, Adriana Ibarra, et al.
Publicado: (2023)

DIPG-78. REVERTANCE OF THE H3K27M MUTATION RESCUES CHROMATIN MARKS NECESSARY FOR ONCOGENESIS IN DIFFUSE MIDLINE GLIOMA
por: Nesvick, Cody, et al.
Publicado: (2020)

DIPG-45. ELONGIN B REGULATES H3K27M CHROMATIN INCORPORATION TO PROMOTE MALIGNANCY IN DIFFUSE MIDLINE GLIOMA
por: Anastas, Jamie, et al.
Publicado: (2023)

HGG-12. HUMAN IPSC-DERIVED H3.3K27M NEUROSPHERES: A NOVEL MODEL FOR INVESTIGATING DIPG PATHOGENESIS AND DRUG RESPONSE
por: Skinner, Kasey, et al.
Publicado: (2021)

Chromatin Environment of Histone Variant H3.3 Revealed by Quantitative Imaging and Genome-scale Chromatin and DNA Immunoprecipitation
por: Delbarre, Erwan, et al.
Publicado: (2010)

DIPG-50. Bioinformatic evaluation of genes involved in sphingomyelin biosynthesis in Diffuse Midline Glioma H3K27 altered/DIPG: dysregulation of sphingosine 1-phosphate (SP1)
por: Humphreys, Aimee, et al.
Publicado: (2022)

The N terminus of Ascl1 underlies differing proneural activity of mouse and Xenopus Ascl1 proteins
por: Hardwick, Laura J.A., et al.
Publicado: (2018)

ASCL1 regulates neurodevelopmental transcription factors and cell cycle genes in brain tumors of glioma mouse models
por: Vue, Tou Yia, et al.
Publicado: (2020)

Transcription-coupled recruitment of human CHD1 and CHD2 influences chromatin accessibility and histone H3 and H3.3 occupancy at active chromatin regions
por: Siggens, Lee, et al.
Publicado: (2015)

Correction for Chromatin Environment of Histone Variant H3.3 Revealed by Quantitative Imaging and Genome-scale Chromatin and DNA Immunoprecipitation
Publicado: (2010)

Multimodal epigenetic changes and altered NEUROD1 chromatin binding in the mouse hippocampus underlie FOXG1 syndrome
por: Akol, Ipek, et al.
Publicado: (2023)

PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3
por: Benitez, Jorge A., et al.
Publicado: (2017)

DIPG-27. Behavioral disturbances as underestimated presenting symptoms in children with Diffuse Intrinsic Pontine Glioma (DIPG)
por: Milanaccio, Claudia, et al.
Publicado: (2022)

DIPG-27. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) CHALLENGE: FROM GENE EXPRESSION PROFILE TO DRUG
por: Scilimati, Antonio, et al.
Publicado: (2023)

Histone H3 genotyping refines clinico-radiological diagnostic and prognostic criteria in DIPG
por: Castel, David, et al.
Publicado: (2016)

HGG-33. EXPLOITING METABOLIC DEFECTS WITH NAMPT INHIBITORS IN DIPG
por: Muraleedharan, Ranjithmenon, et al.
Publicado: (2021)

DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG
por: Gardner, Sharon, et al.
Publicado: (2020)

Histone H1 facilitates restoration of H3K27me3 during DNA replication by chromatin compaction
por: Liu, Cuifang, et al.
Publicado: (2023)

Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG
por: Balakrishnan, Ilango, et al.
Publicado: (2020)

HGG-08. CREATION OF AN IN VITRO AND IN VIVO MODEL SYSTEM FOR THE STUDY OF H3.1K27M DIPG
por: Lagas, Joseph, et al.
Publicado: (2021)

CTCF induces histone variant incorporation, erases the H3K27me3 histone mark and opens chromatin
por: Weth, Oliver, et al.
Publicado: (2014)

Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG
por: Nikolaev, Anatoly, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eja58afs4cj1tppv24m8irqbco